Hims & Hers Health, Inc. (HIMS)

NYSE: HIMS · USD

$29.4

+1.45 (+5.2%)· Recorded snapshot

Market cap	6.9B
Revenue (ttm)	2.6B
Net income (ttm)	-142M
EPS (ttm)	-$0.62
Shares out	233.3M
P/E (forward)	84.9x
Volume	11,206,289
Beta	2.43

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.6B
Net income (ttm): -142M
EPS (ttm): -$0.62
P/E (forward): 84.9x
Market cap: 6.9B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E84.9

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-32

P25 n/aP50 n/aP75 n/a

ROIC-10.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All HIMS indicators

Market & fundamental data

Available fields

226

Groups with data

Currency

USD

Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001773751
Company name	Hims & Hers Health, Inc.
Country	United States
Country code	US
CUSIP number	433000106
Earnings date	2026-11-09
Earnings time	amc
Employees	2,442
Employees change	805
Employees growth	49.18%
Enterprise value	$7.6B
Exchange	NYSE
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
Is SPAC	No
ISIN number	US4330001060
Last 10-K release date	2026-02-23
Last earnings date	2026-08-10
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$6.9B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$29.37
Price currency	USD
Sector	Healthcare
SIC code	8011
Stock price date	2026-10-28
Symbol	HIMS
U.S. state	California
Website	https://www.hims.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Adjusted P/E ratio	130.24x
Earnings yield	-2.12%
EV/FCF	91.81x
EV/Sales	2.96x
FCF / EV yield	1.09%
FCF yield	1.2%
Forward EV/Sales	2.07x
Forward P/E	84.92x
Forward P/S	1.88x
Industry forward P/E	13.86x
Industry P/E	173.47x
P/(OCF - SBC) ratio	63x
P/B ratio	20.1x
P/FCF ratio	83.32x
P/OCF ratio	26.26x
P/S ratio	2.68x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-3.78%
EBITDA margin	-0.39%
FCF margin	3.22%
Gross margin	69.53%
Operating margin	-3.78%
Pretax margin	-6.35%
Profit margin	-5.51%
Profit per employee	$-58,161
Profitable years	2
Revenue per employee	$1.1M
ROA	-2.21%
ROA (5Y)	-5.39%
ROCE	-4.54%
ROE	-32.03%
ROE (5Y)	-4.15%
ROIC	-10.49%
SBC / revenue	5.96%
Tax / revenue	-0.84%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
FCF growth	-37.28%
FCF growth 3Y	67.01%
Gross profit growth	16.83%
Gross profit growth (Q)	15.52%
Gross profit growth 3Y	46.48%
Gross profit growth 5Y	64.09%
Net income growth years	4
OCF growth	0.7%
OCF growth 3Y	117.58%
Revenue growth	28.04%
Revenue growth (Q)	38.25%
Revenue growth (QoQ)	23.86%
Revenue growth 3Y	53.65%
Revenue growth 5Y	67.46%
Revenue growth quarters	23
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-180.4M
Depreciation and amortization	$87.2M
EBIT	$-97.4M
EBITDA	$-10.2M
EPS	$-0.62
FCF per share	$0.36
Financing cash flow	$127.3M
Free cash flow	$83M
Free cash flow minus SBC	$-70.6M
Gross profit	$1.8B
Income taxes	$-21.6M
Investing cash flow	$-902M
Net borrowing	$390.4M
Net cash flow	$-515.1M
Net income	$-142M
Operating cash flow minus SBC	$109.8M
Operating income	$-97.4M
Revenue	$2.6B
Stock-based compensation	$153.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.98
Book value per share	$1.39
Debt / EBITDA	171.37
Debt / equity	4.77
Debt / FCF	18.62
Goodwill	$1.1B
Interest coverage	-10.44
Long-term assets	$2.2B
Long-term liabilities	$1.8B
Net cash (debt)	$-705.2M
Net cash / market cap	-10.19%
Net debt / equity	2.18
Net debt / FCF	8.49
Piotroski F-Score	2
Property, plant and equipment	$529.8M
Shareholders' equity	$324.1M
Tangible book value	$-1.2B
Tangible book value per share	$-5.15
Total assets	$3.6B
Total cash	$841M
Total debt	$1.5B
Total liabilities	$3.3B
WACC	14.49%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.94
Current assets	$1.4B
Current liabilities	$1.5B
Current ratio	0.93
Inventory turnover	6.84
Net working capital	$-928.1M
Quick ratio	0.82
Working capital	$-98.6M
Working capital turnover	5.24

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.33%
Dividend yield	0%
Shareholder yield	7.33%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$28.59
1D price change	5.19%
1M price change	-0.17%
1M total return	-0.17%
1W price change	0.55%
1W total return	0.55%
1Y price change	-39.1%
1Y return CAGR	-39.12%
1Y total return	-39.1%
20-day SMA	$28.99
200-day SMA	$27.06
3M price change	-2.88%
3M total return	-2.88%
3Y price change	408.13%
3Y return CAGR	71.9%
3Y total return	408.13%
50-day SMA	$29.15
50-day SMA vs 200-day SMA	50over200
52-week high	$49.17
52-week high date	2025-10-28
52-week low	$13.74
52-week low date	2026-02-24
5Y price change	294.76%
5Y return CAGR	31.61%
5Y total return	294.76%
6M price change	-0.07%
6M total return	-0.07%
All-time high	$72.98
All-time high date	2025-02-19
All-time low	$2.72
All-time low date	2022-05-12
Average true range (ATR)	$1.72
Average volume	9.7M
Beta (1Y)	2.74
Beta (2Y)	2.5
Beta (5Y)	2.43
Change from 52-week high	-40.27%
Change from 52-week low	113.76%
Change from all-time high	-59.76%
Change from all-time low	979.78%
Change from open	5.99%
Day's gap	-0.75%
Dollar volume	$329.1M
High price	$29.80
Low price	$27.70
Monthly RSI	49.78
Open price	$27.71
Position in 52-week range	79.52%
Premarket change	-0.18%
Premarket close	$27.92
Premarket price	$27.87
Premarket volume	79.7K
Previous close	$27.92
Price vs 150-day SMA	2.74%
Price vs 20-day SMA	1.31%
Price vs 200-day SMA	8.53%
Price vs 50-day SMA	0.75%
Relative volume	1.17
RSI	52.24
Sharpe ratio	-0.18
Sharpe ratio (3Y)	0.98
Sharpe ratio (5Y)	0.67
Sortino ratio	-0.21
Sortino ratio (3Y)	1.6
Sortino ratio (5Y)	1.12
Volume	11.2M
Weekly RSI	50.47
YTD price change	-9.55%
YTD total return	-9.55%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	213.8M
Float percentage	91.62%
Shares change (QoQ)	1.48%
Shares change (YoY)	-7.33%
Shares held by insiders	8.36%
Shares held by institutions	66.7%
Shares outstanding	233.3M
Short % of float	25.62%
Short % of shares	23.47%
Short ratio	5.8 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	190

Deeper analysis on HIMS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this HIMS report

Is a complete HIMS research report available?

No complete published report is available for Hims & Hers Health, Inc. (HIMS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Hims & Hers Health, Inc. (HIMS)

Price

Financial snapshot

Fair-value bridge

Latest news · HIMS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HIMS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on HIMS

Frequently asked questions